Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The HIF pathway in cancer.

Patrick H Maxwell1

  • 1Renal Section, Hammersmith Campus, Imperial College London, Du Cane Road, London W12 0NN, UK. p.maxwell@imperial.ac.uk

Seminars in Cell & Developmental Biology
|September 8, 2005
PubMed
Summary

Hypoxia-inducible factor-1 (HIF) is often activated in cancer, impacting gene expression and tumor growth. Understanding HIF

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A framework for the exploration of subcellular compartmentalization of RNA-binding proteins.

Nature communications·2026
Same author

Author Correction: Rolling back human pluripotent stem cells to an eight-cell embryo-like stage.

Nature·2025
Same author

AI education for clinicians.

EClinicalMedicine·2024
Same author

Lifespan Extension by Retrotransposons under Conditions of Mild Stress Requires Genes Involved in tRNA Modifications and Nucleotide Metabolism.

International journal of molecular sciences·2024
Same author

Hypoxia drives HIF2-dependent reversible macrophage cell cycle entry.

Cell reports·2024
Same author

A spatiotemporal atlas of mouse liver homeostasis and regeneration.

Nature genetics·2024

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Hypoxia-inducible factor-1 (HIF) is frequently activated in various cancers.
  • HIF activation influences critical processes like gene expression and tumor angiogenesis.
  • Genetic alterations in cancer, such as VHL tumor suppressor loss, lead to constitutive HIF pathway activation.

Purpose of the Study:

  • To elucidate the role of HIF activation in the progression of diverse cancer types.
  • To investigate the potential of targeting the HIF pathway for cancer therapy.

Main Methods:

  • Analysis of gene expression patterns associated with HIF activation.
  • Investigation of tumor angiogenesis in the context of HIF.
  • Correlation of VHL gene status with HIF pathway activity.

Main Results:

  • HIF activation significantly impacts cancer-related gene expression.
  • HIF plays a crucial role in promoting tumor angiogenesis.
  • Loss of VHL function is a key driver of constitutive HIF activation in cancer.

Conclusions:

  • HIF activation is a significant factor in cancer evolution.
  • Targeting the HIF pathway presents a promising therapeutic strategy for cancer treatment.

Related Experiment Videos